About
Dr. Peter Li joined Nexcelom Biosciences as CEO in 2006. Alongside founder Dr. Jean Qiu, he led the company's growth over more than a decade, building it into a maker of cell analysis instruments and reagents. In 2017, the company partnered with Ampersand Capital Partners to support its expansion.
Colleagues at Ampersand
Aditya V. Goel
Associate at Ampersand
Benoit P. Bouche
Operating Partner at Ampersand
Cole S. Aldrich
Senior Associate at Ampersand
David Q. Anderson
General Partner at Ampersand
Dean D. Schauer
Operating Partner at Ampersand
Elias J. Laimboeck
Senior Associate at Ampersand
Emanuele M. Delfino
Associate at Ampersand
Eric B. Lev
General Partner at Ampersand
Frequently asked questions
- Who is Peter Li?
- Dr. Peter Li joined Nexcelom Biosciences as CEO in 2006. Alongside founder Dr. Jean Qiu, he led the company's growth over more than a decade, building it into a maker of cell analysis instruments and reagents. In 2017, the company partnered with Ampersand Capital Partners to support its expansion.
- Where does Peter Li work?
- Peter Li is CEO of Nexcelom (joined 2006) at Ampersand.